MDS | Tumor

CURE’s myelodysplastic syndrome (MDS) page is an extensive resource of cancer information featuring the latest myelodysplastic syndrome news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on MDS.

My New, Side Effect-Free Cancer Treatment Makes Me Feel Like 'a Kid in a Toy Store'

September 14th 2022, 5:00pm

Article

My new cancer treatment hardly has any side effects, making me wonder if researchers are focusing on making their drugs more tolerable for patients.

Cancer Survivors Must Bloom Where Planted

September 1st 2022, 5:00pm

Article

The last year was tough, but with a new cancer treatment center and other opportunities, I’m going to sit tight and bloom where planted.

FDA Lifts Partial Hold on Blood Cancer Trial, Patient Enrollment Allowed to Continue

August 31st 2022, 7:00pm

Article

The FDA’s decision allows patients with relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndrome — types of blood cancer — to continue enrolling on the TakeAim Leukemia trial.

FDA Stops Study of Novel Blood Cancer Drug

August 23rd 2022, 9:00pm

Article

The Food and Drug Administration put a full clinical hold on a study of the novel drug FHD-286 in patients with acute myelogenous leukemia and myelodysplastic syndrome after study data showed an increase in a potentially fatal side effect.

I’m Still Alive With Cancer, But I Want More

August 17th 2022, 5:00pm

Article

Cancer and COVID-19 took away my yearly “benchmarks” of time, when I fly out to see friends and family.

Be Kind to Yourself in Cancer Survivorship

August 10th 2022, 5:00pm

Article

I must remember to be kind to myself, and not compare my current abilities to my pre-cancer days.

Trial to Compare Safety and Efficacy of Novel Cell Therapy to Standard of Care in Patients With Rare Blood Cancers

August 3rd 2022, 9:00pm

Article

Enrollment has begun on a phase 3 clinical trial assessing the safety and efficacy of an investigational cell therapy in patients with acute myeloid leukemia, acute lymphocytic leukemia and myelodysplastic syndromes.

Novel Drug-Chemotherapy Combo After Stem Cell Transplant Associated With ‘Favorable Survival Outcomes’ in Group of Rare Blood Cancers

July 26th 2022, 7:00pm

Article

The findings support future studies of assessing the safety and efficacy of the novel drug-chemotherapy combination as a maintenance strategy following stem cell transplantation across a range of blood cancers, according to the study authors.

I Have the Best of Both Worlds: A Local Cancer Center and a Research Center

July 14th 2022, 5:00pm

Article

The decision to be treated locally or at a large research center can be a difficult one, but I am lucky enough to have both.

Cancer Exacerbated My COVID-19 Fatigue

June 14th 2022, 9:00pm

Article

I’ve experienced fatigue from cancer before but contracting COVID-19 took it to a whole other level.